These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19356116)

  • 1. Impact of time-dependent inactivation on the estimation of enzyme kinetic parameters for midazolam.
    Giragossian C; LaPerle J; Kosa RE; Gillian S
    Drug Metab Lett; 2009 Jan; 3(1):45-53. PubMed ID: 19356116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography-mass spectrometry.
    Kanazawa H; Okada A; Igarashi E; Higaki M; Miyabe T; Sano T; Nishimura R
    J Chromatogr A; 2004 Mar; 1031(1-2):213-8. PubMed ID: 15058585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of medetomidine, atipamezole and midazolam in pig plasma by liquid chromatography-mass spectrometry.
    Kanazawa H; Nishimura R; Sasaki N; Takeuchi A; Takai N; Nagata Y; Matsushima Y
    Biomed Chromatogr; 1995; 9(4):188-91. PubMed ID: 8520209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.
    Polasek TM; Miners JO
    Eur J Clin Pharmacol; 2006 Mar; 62(3):203-8. PubMed ID: 16416302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes.
    Mao J; Johnson TR; Shen Z; Yamazaki S
    Drug Metab Dispos; 2013 Feb; 41(2):343-52. PubMed ID: 23129213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
    Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an LC-MS/MS Method for the Determination of Propofol, Midazolam, and Carbamazepine in Rat Plasma: Application to Monitor Their Concentrations Following Co-administration.
    El Hamd MA; Wada M; Ikeda R; Kawakami S; Nakashima K
    Biol Pharm Bull; 2015; 38(8):1250-3. PubMed ID: 26235591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats.
    Vuppugalla R; Zhang Y; Chang S; Rodrigues AD; Marathe PH
    Xenobiotica; 2012 Nov; 42(11):1058-68. PubMed ID: 22574883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A maturation model for midazolam clearance.
    Anderson BJ; Larsson P
    Paediatr Anaesth; 2011 Mar; 21(3):302-8. PubMed ID: 20704661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What changes drug metabolism in critically ill patients--III? Effect of pre-existing disease on the metabolism of midazolam.
    Park GR; Miller E
    Anaesthesia; 1996 May; 51(5):431-4. PubMed ID: 8694153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
    Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
    Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection.
    Lepper ER; Hicks JK; Verweij J; Zhai S; Figg WD; Sparreboom A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):305-10. PubMed ID: 15171944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.
    Hamaoka N; Oda Y; Hase I; Mizutani K; Nakamoto T; Ishizaki T; Asada A
    Clin Pharmacol Ther; 1999 Aug; 66(2):110-7. PubMed ID: 10460064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol reduces the distribution and clearance of midazolam.
    Lichtenbelt BJ; Olofsen E; Dahan A; van Kleef JW; Struys MM; Vuyk J
    Anesth Analg; 2010 Jun; 110(6):1597-606. PubMed ID: 20435936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.
    Mc Donnell CG; Shorten G; Van Pelt FN
    Anaesthesia; 2005 Aug; 60(8):747-53. PubMed ID: 16029222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
    Peeters MY; Prins SA; Knibbe CA; Dejongh J; Mathôt RA; Warris C; van Schaik RH; Tibboel D; Danhof M
    Anesthesiology; 2006 Dec; 105(6):1135-46. PubMed ID: 17122576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats.
    Zhang X; Galinsky RE; Kimura RE; Quinney SK; Jones DR; Hall SD
    Drug Metab Dispos; 2010 Jan; 38(1):61-72. PubMed ID: 19797607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.